The Uromigos

401 Épisodes

1. Episode 403: ADCs in Bladder Cancer. Part 2 from the Canary Islands

   Publié: 02/04/2025
2. Episode 402: Uromigos en Espanol: Futuro del carcinoma de células renales

   Publié: 31/03/2025
3. Episode 401: ADCs in Bladder Cancer. Part 1 from the Canary Islands

   Publié: 29/03/2025
4. Episode 400: The Uromigos Score for Urothelial Cancer

   Publié: 28/03/2025
5. Episode 399: A PD1/VEGF Bispecific in Lung Cancer - Lessons for GU Cancers?

   Publié: 24/03/2025
6. Episode 398: Reflections on the Felix Feng Symposium at ASCO GU

   Publié: 17/03/2025
7. Episode 397: APCCC Diagnostics Conference recap

   Publié: 10/03/2025
8. Episode 396: Uromigos Japan - 激論 @JSMO25

   Publié: 09/03/2025
9. Episode 395: Uromigos Japan: ASCO GU 2025のレビュー

   Publié: 03/03/2025
10. Episode 394: APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025

    Publié: 01/03/2025
11. Episode 393: ASCO GU 2025 Review Podcast

    Publié: 26/02/2025
12. Episode 392: ASCO GU 2025 - HIF Inhibition with Casdatifan in Refractory RCC

    Publié: 15/02/2025
13. Episode 391: ASCO GU 2025 - KIM-1 Data from Checkmate 214

    Publié: 15/02/2025
14. Episode 390: ASCO GU 2025 - Pembro-based Doublets in Refractory RCC and COSMIC-313 OS Update

    Publié: 15/02/2025
15. Episode 388: ASCO GU 2025 - FGF3 Inhibition with LOXO-435 in Urothelial Cancer

    Publié: 15/02/2025
16. Episode 387: ASCO GU 2025 -Neoadjuvant Disitamab Vedotin + Toripalimab in HER2+ MIBC: updated efficacy and safety results

    Publié: 14/02/2025
17. Episode 389: ASCO GU 2025 - NIAGARA Pathologic CR Updates and Outcomes

    Publié: 14/02/2025
18. Episode 386: ASCO GU 2025 - APRI Meta-analysis

    Publié: 13/02/2025
19. Episode 385: ASCO GU 2025 - TALAPRO-2

    Publié: 13/02/2025
20. Episode 384: ASCO GU Preview

    Publié: 06/02/2025